Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

43.07
-0.9400-2.14%
Post-market: 43.110.0400+0.09%19:59 EDT
Volume:11.03M
Turnover:474.48M
Market Cap:192.31B
PE:10.76
High:43.50
Open:43.20
Low:42.72
Close:44.01
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.35
T/O Rate:0.35%
Dividend:1.72
Dividend Rate:4.00%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.91
PE(LYR):11.90

Loading ...

Novo Nordisk Faces Growth Concerns Ahead of Important Investor Day

Dow Jones
·
Aug 27

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 27

Movement Alert|Novo-Nordisk A/S Declines 3.01% in Regular Trading, Trading at $47.24

Market Focus
·
Aug 26

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Aug 26

DBS Reaffirms Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
Aug 26

Novo Nordisk (NVO) Stock May Trade Below Fair Value Despite Obesity Market Lawsuit

Simply Wall St.
·
Aug 26

Novo Nordisk A/S Stock (NVO) Closed Up by 3.71% on Aug 25: A Full Analysis

TradingKey
·
Aug 26

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
Aug 26

Novo Nordisk price target raised to DKK 275 from DKK 250 at JPMorgan

TIPRANKS
·
Aug 26

Novo Nordisk call volume above normal and directionally bullish

TIPRANKS
·
Aug 25

Movement Alert|Novo-Nordisk A/S Rises 3.01% in Regular Trading, JPMorgan Raises Target Price to 275 DKK

Market Focus
·
Aug 25

Novo Nordisk Sales Growth Could Remain Flat This Year

Dow Jones
·
Aug 25

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Aug 25

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Aug 25

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

TIPRANKS
·
Aug 25

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 25

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Aug 24

Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk

Dow Jones
·
Aug 24

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

TIPRANKS
·
Aug 24

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 22